World's Best Scientists 2026 revealed!
Markus Huber-Lang

Markus Huber-Lang

D-Index & Metrics

Immunology

D-Index
81
Citations
24912
World Ranking
1559
National Ranking
108

Markus Huber-Lang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Markus Huber-Lang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 398 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Markus Huber-Lang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Markus Huber-Lang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Markus Huber-Lang is affiliated with the University of Ulm in Germany and has an extensive publication record in the fields of medicine and immunology. Their work primarily focuses on the complement system's role in disease processes, immune response mechanisms, and trauma-related pathophysiology.

Their published research spans various topics including:

  • Complement system in diseases
  • Immune response and inflammation
  • Sepsis diagnosis and treatment
  • Neutrophil, myeloperoxidase, and oxidative mechanisms
  • COVID-19 clinical research studies
  • Trauma and emergency care studies
  • Traumatic brain injury and neurovascular disturbances

Among recent notable papers involving or related to their research area are:

  • Complement as a target in COVID-19? (2020, Nature Reviews Immunology)
  • The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 (2020, Clinical Immunology)
  • Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy (2020, Clinical Immunology)
  • Immunopathophysiology of trauma-related acute kidney injury (2020, Nature Reviews Nephrology)
  • Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions (2021, Journal of Innate Immunity)

The frequent co-authors working alongside Markus Huber-Lang include:

  • Rebecca Halbgebauer
  • Marco Mannes
  • Bo Nilsson
  • David Alexander Christian Messerer
  • Annette Palmer

Their research outputs have been published in various scientific venues, notably:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Immunobiology
  • Shock
  • International Journal of Molecular Sciences

Markus Huber-Lang has also contributed to book publications, with a title addressing clinical course and organ cross talk in critical illness released by Frontiers Media in 2023.

Within their academic disciplines, their work is concentrated in the subfields of immunology, molecular biology, epidemiology, neurology, and surgery, further demonstrating a multidisciplinary approach.

Best Publications

  • Immunodesign of experimental sepsis by cecal ligation and puncture.

    Daniel Rittirsch;Markus S Huber-Lang;Michael A Flierl;Peter A Ward

  • Generation of C5a in the absence of C3: a new complement activation pathway.

    Markus Huber-Lang;J Vidya Sarma;Firas S Zetoune;Daniel Rittirsch

  • Molecular Intercommunication between the Complement and Coagulation Systems

    Umme Amara;Michael A. Flierl;Daniel Rittirsch;Andreas Klos

  • Innate immune responses to trauma

    Markus Huber-Lang;John D. Lambris;Peter A. Ward

  • Phagocyte-derived catecholamines enhance acute inflammatory injury

    Michael A. Flierl;Daniel Rittirsch;Brian A. Nadeau;Anthony J. Chen

  • Complement as a target in COVID-19?

    Antonio M. Risitano;Dimitrios C. Mastellos;Markus Huber-Lang;Despina Yancopoulou

  • Protective effects of C5a blockade in sepsis

    Boris J. Czermak;Vidya Sarma;Carl L. Pierson;Roscoe L. Warner

  • Functional roles for C5a receptors in sepsis

    Daniel Rittirsch;Michael A Flierl;Brian A Nadeau;Danielle E Day

  • Role of C5a in Multiorgan Failure During Sepsis

    Markus Huber-Lang;Vidya J. Sarma;Kristina T. Lu;Stephanie R. McGuire

  • Generation of C5a by phagocytic cells.

    Markus Huber-Lang;Ellen M. Younkin;J. Vidya Sarma;Niels Riedemann

  • New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System

    Christian Ehrnthaller;Anita Ignatius;Florian Gebhard;Markus Huber-Lang

  • The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.

    Sara Mastaglio;Annalisa Ruggeri;Antonio M. Risitano;Piera Angelillo

  • Complement-induced impairment of innate immunity during sepsis.

    Markus S. Huber-Lang;Ellen M. Younkin;J. Vidya Sarma;Stephanie R. McGuire

  • Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS) : an international expert consensus initiative for improvement of animal modeling in sepsis

    Marcin F. Osuchowski;Alfred Ayala;Soheyl Bahrami;Michael Bauer

  • Adverse functions of IL-17A in experimental sepsis

    Michael A. Flierl;Daniel Rittirsch;Hongwei Gao;Laszlo M. Hoesel

  • Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.

    Dimitrios C. Mastellos;Bruno G.P. Pires da Silva;Benedito A.L. Fonseca;Natasha P. Fonseca

  • Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

    Michael A. Flierl;Daniel Rittirsch;Markus Huber-Lang;J. Vidya Sarma

  • Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.

    Anita Ignatius;Philipp Schoengraf;Ludwika Kreja;Astrid Liedert

  • Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis

    Marcin F. Osuchowski;Alfred Ayala;Soheyl Bahrami;Michael Bauer

  • Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

    David Braig;David Braig;Tracy L. Nero;Hans Georg Koch;Benedict Kaiser

  • Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis

    Ines J. Laudes;Jeffrey C. Chu;Sujata Sikranth;Markus Huber-Lang

  • Protection of innate immunity by C5aR antagonist in septic mice

    Markus S. Huber-Lang;Niels C. Riedeman;J. Vidya Sarma;Ellen M. Younkin

  • Expression and function of C5a receptor in mouse microvascular endothelial cells.

    Ines J. Laudes;Jeffrey C. Chu;Markus Huber-Lang;Ren Feng Guo

Frequent Co-Authors

Peter A. Ward
Peter A. Ward University of Michigan–Ann Arbor
John D. Lambris
John D. Lambris University of Pennsylvania
J. Vidya Sarma
J. Vidya Sarma University of Michigan–Ann Arbor
Hubert Schrezenmeier
Hubert Schrezenmeier University of Ulm
Bo Nilsson
Bo Nilsson Uppsala University
Jörg Köhl
Jörg Köhl University of Lübeck
Kristina Nilsson Ekdahl
Kristina Nilsson Ekdahl Uppsala University
Tom Eirik Mollnes
Tom Eirik Mollnes Oslo University Hospital
Michael K. Georgieff
Michael K. Georgieff University of Minnesota
Lutz Claes
Lutz Claes University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare and research careers, but many students also consider complementary pathways in nursing. For those interested in expanding their clinical expertise, exploring an fnp to acute care certification can be a strategic move, allowing nurse practitioners to specialize in acute care settings.

Accelerated programs offer an efficient way to earn nursing credentials and enter the workforce faster. Students can choose from options such as accelerated nurse practitioner programs that provide advanced clinical training while fitting a busy schedule through online formats.

For those without prior nursing experience, there are accessible routes like online rn programs for non nurses. These programs help individuals transition smoothly into nursing careers, complementing their background in immunology with practical skills.

Additionally, students seeking faster entry points can consider easiest accelerated nursing programs to get into. These admit qualified candidates quickly, offering a streamlined path to a Bachelor of Science in Nursing, which can enhance career options in immunological research and healthcare.

Best Scientists Citing Markus Huber-Lang

Trending Scientists

Recently Published Articles